Committee Decisions
Committee List
- ASPH DTC
- Commissioning Intentions
- East Surrey CCG Medicines Programme Board
- East Surrey ICP MOG
- Epsom St Helier NDAIG
- ESCCG sub-committee of North Place Alliance Clinical Strategy Committee (formerly Clinical Executive
- Guildford and Waverley MOG
- Medicines Optimisation Operational Group (MOOG)
- Not Set
- NW Surrey CCG Medicines Optimisation Group
- Primary Care Medicines Optimisation Clinical reference Group (PCMOCRG)
- RSCH DTC
- Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
- Surrey Downs CCG MOG
- Surrey Downs CCG Prescribing Leads Meeting
- Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
- Surrey Heartlands Medicines Optimisation Board (MOB)
- Surrey Heartlands Medicines Safety Committee (MSC)
- Surrey Medicines Commissioners Group
- Surrey Priorities Committee
Decisions : Surrey Priorities Committee
Records returned : 1.
Date
Drug Profile
Narrative
Traffic Light Status
Wednesday, March 4, 2015
The Surrey Priorities Committee has considered the PCN evidence review and the NICE ESNM40 (Evidence Summary: New Medicine), regarding dapoxetine for the treatment of premature ejaculation:
The commissioning of dapoxetine for premature ejaculation is considered LOW PRIORITY and it is not recommended for routine prescribing.
Dapoxetine should therefore have a BLACK status on the Surrey traffic light system.
The commissioning of dapoxetine for premature ejaculation is considered LOW PRIORITY and it is not recommended for routine prescribing.
Dapoxetine should therefore have a BLACK status on the Surrey traffic light system.
Black